|
TMEM131 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.391160E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.305770E-01 |
| Normal-vs-Stage2 |
2.797200E-01 |
| Normal-vs-Stage3 |
4.802800E-01 |
| Normal-vs-Stage4 |
4.440400E-01 |
| Stage1-vs-Stage2 |
7.955600E-01 |
| Stage1-vs-Stage3 |
4.733200E-01 |
| Stage1-vs-Stage4 |
7.070000E-01 |
| Stage2-vs-Stage3 |
5.169400E-01 |
| Stage2-vs-Stage4 |
6.243800E-01 |
| Stage3-vs-Stage4 |
8.700800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.510190E-01 |
| Normal-vs-AfricanAmerican |
9.441100E-03 |
| Normal-vs-Asian |
4.451900E-02 |
| Caucasian-vs-AfricanAmerican |
1.121430E-01 |
| Caucasian-vs-Asian |
2.096200E-01 |
| AfricanAmerican-vs-Asian |
5.822000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.011210E-01 |
| Normal-vs-Female |
2.179200E-01 |
| Male-vs-Female |
4.143400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.785500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.464800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.793800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.534580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.063400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.559800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.546800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.632200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.482600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.259600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.079600E-01 |
| Classical-VS-Follicular |
1.97487999999968E-05 |
| Classical-VS-Other |
4.235500E-02 |
| Classical-VS-Normal |
3.823500E-03 |
| Tall-VS-Follicular |
6.007700E-02 |
| Tall-VS-Other |
1.572050E-01 |
| Tall-VS-Normal |
5.054400E-01 |
| Follicular-VS-Other |
8.216600E-01 |
| Follicular-VS-Normal |
1.093400E-01 |
| Other-VS-Normal |
2.015000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.399400E-01 |
| Normal-vs-N1 |
8.538600E-01 |
| N0-vs-N1 |
8.604000E-01 |
|
|
